Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong, F. Ann Ran, David Cox et al. · Science · 2013
Functional elucidation of causal genetic variants and elements requires precise genome editing technologies. The type II prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats)/Cas adaptive immune system has been shown to facilitate RNA-guided site-specific DNA cleavage. We engineered two different type II CRISPR/Cas systems and demonstrate that Cas9 nucleases can be directed by short RNAs to induce precise cleavage at endogenous genomic loci in human and mouse cells. Cas9 can also be converted into a nicking enzyme to facilitate homology-directed repair with minimal mutagenic activity. Lastly, multiple guide sequences can be encoded into a single CRISPR array to enable simultaneous editing of several sites within the mammalian genome, demonstrating easy programmability and wide applicability of the RNA-guided nuclease technology.
Cited by 15,289 works. doi:10.1126/science.1231143
Authors
- Le Cong
- F. Ann Ran
- David Cox
- Shuailiang Lin
- Robert P. J. Barretto
- Naomi Habib
- Patrick D. Hsu
- Xuebing Wu
- Wenyan Jiang
- Luciano A. Marraffini
- Feng Zhang
References
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
- RNA-Guided Human Genome Engineering via Cas9
- CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
- Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes
- A TALE nuclease architecture for efficient genome editing
- Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
- CRISPR/Cas, the Immune System of Bacteria and Archaea
- Mechanisms of gene silencing by double-stranded RNA
- Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
- Evolution and classification of the CRISPR–Cas systems